v3.26.1
Equity Transactions (Tables)
9 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of summarizes the activity relating to the Company’s stock options
                    
   Options   Weighted-Average Exercise Price   Weighted Remaining Average Contractual Term   Aggregate Intrinsic Value 
Outstanding at June 30, 2025   84,872   $286.20    6.2   $- 
Options Granted   2,706,550   $1.31    7.6   $243,590 
Options Expired   (6,059)  $1,091.98    0.0   $- 
Outstanding at March 31, 2026   2,785,363   $7.62    7.6   $243,590 
Exercisable at March 31, 2026   1,606,299   $10.51    7.4   $139,018 
Schedule of assumptions used
          
   March 31, 2026   March 31, 2025 
Expected life of options (in years)   5    4 
Expected volatility   89.31%   93.44%
Risk free interest rate   3.69%   4.34%
Dividend Yield   0%   0%
Schedule of vesting of restricted common stock
          
   Number of Shares   Weighted Average Grant Date Fair Value Per Share 
Unvested at June 30, 2025   7,213   $116.41 
Granted   1,500    1.58 
Vested   (7,614)   83.67 
Unvested at March 31, 2026   1,099   $187.02 
Summary of warrants activity
                    
   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Life (Years)   Aggregate Intrinsic Value 
Outstanding and exercisable at June 30, 2025   960,098   $35.02    4.1   $- 
Granted   6,967,300    2.50    5.0    - 
Canceled   (25,001)   150.00    -    - 
Expired   (360)   1,250.00    -    - 
Outstanding and exercisable at March 31, 2026   7,902,037   $5.82    4.2   $- 
Schedule of expiration of the warrants outstanding
     
   Number of Warrants 
     
Expiring June 30,     
2027   3,610 
2028   72,728 
2029   90,508 
2030   767,891 
2031   6,967,300 
Total outstanding warrants   7,902,037